Actively Recruiting
Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"
Led by Federico II University · Updated on 2025-08-12
100
Participants Needed
4
Research Sites
147 weeks
Total Duration
On this page
Sponsors
F
Federico II University
Lead Sponsor
U
University of Roma La Sapienza
Collaborating Sponsor
AI-Summary
What this Trial Is About
Obesity is a life-threatening disease, defined by excessive fat accumulation that increases the risk of other diseases such as cardiovascular events, hypertension, diabetes and cancer. Obesity is also a risk factor for nosocomial infections and is associated with worse COVID-19 outcomes, although anthropometric measurements are not routinely recorded during hospitalization and lack of a registry data does not allow performing retrospective studies.Obesity is closely related to chronodisruption, characterized by deregulation of physiological and behavioral central and peripheral circadian rhythms contributing to the obesity-related metabolic impairment. Eating and sleeping time schedules are relevant synchronizers of humans' biological clock. Several studies suggest a role of dietary interventions in rewiring the circadian rhythm, with Mediterranean diet (MD) regulating nutritional patterns. Moreover, considering its positive impact on sleep quality, melatonin intake was suggested as a potential regulator of circadian rhythms. The relation between chronodisruption, obesity and infections has not been investigated, and a first proof of concept (Pilot study) will aim at investigating it. Three cohorts of obese patients with different aetiology (essential obesity, obesity with type 2 diabetes, genetic forms of obesity) and a cohort of lipodystrophic patients will be enrolled in the study, which is designed as a two-phases protocol. During the first phase (0-12 weeks (w)) patients will be subjected to dietary intervention with hypocaloric MD; in a second phase (12-24w), melatonin 1mg/die before sleep will be added to the hypocaloric MD. The susceptibility to infections will be investigated through the evaluation of 1) the number of events - i.e. flu- or flulike syndromes, skin, respiratory, digestive, urinary infections-per patient of the 4 groups and the blood assays to detect the infection with Epstein-Barr, Cytomegalovirus, Varicella, Measles and SARS-CoV-2 IgG and IgM; hepatitis C and hepatitis B core antibodies and Quantiferon TB Gold, 2) the clock genes rhythm and TLRs expression in patient immune cells at baseline, 12w and 24w.The mutual relationship between biomedical values, environmental and social conditions, and lifestyle habits will be evaluated by structured questionnaires. Validation of questionnaires to explore the susceptibility to infections is another delivery planned for the current study.
CONDITIONS
Official Title
Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Essential obesity with BMI between 30 and 35 Kg/m2
- Genetic forms of obesity with BMI between 30 and 35 Kg/m2
- Obesity with BMI between 30 and 35 Kg/m2 associated with type 2 diabetes
- Obesity with BMI between 30 and 35 Kg/m2 associated with endocrinopathies
- Diagnosis of lipodystrophy
You will not qualify if you...
- Pregnancy or breastfeeding
- Alcohol or drug abuse
- Known severe blood, heart, liver, kidney, or mental diseases
- Presence of hypogonadism
- Current hormonal treatments including estroprogestins
- Intolerance to melatonin or its excipients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
"Federico II" University of Naples, Department of Clinical and Molecular Endocrinology and Oncology
Naples, Italy, 80131
Actively Recruiting
2
Università del Piemonte Orientale
Novara, Italy, 28100
Actively Recruiting
3
University of Pisa
Pisa, Italy, 56126
Actively Recruiting
4
"Sapienza" University of Rome
Roma, Italy, 00161
Actively Recruiting
Research Team
A
Annamaria Colao, Prof
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here